| Investor | Long Focus Capital Management, Llc |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Long Focus Capital Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G | ONIT / Onity Group Inc. | 652,088 | 540,598 | ||||
| 2026-05-15 | 13G | TLYS / Tilly's, Inc. | 1,712,130 | 0 | ||||
| 2026-05-15 | 13G | BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) | 3,310,687 | |||||
| 2026-02-17 | 13G | ADAPY / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) | 20,494,393 | 0 | ||||
| 2025-11-14 | 13G | FIP / FTAI Infrastructure Inc. | 5,701,162 | 5,685,000 | ||||
| 2025-11-14 | 13G | TLYS / Tilly's, Inc. | 2,181,931 | 1,712,130 | ||||
| 2025-11-14 | 13G | CTRN / Citi Trends, Inc. | 440,000 | 242,668 | ||||
| 2025-08-14 | 13G | AZULQ / Azul S.A. - Depositary Receipt (Common Stock) | 5,632,943 | 0 | ||||
| 2025-08-14 | 13G | CTRN / Citi Trends, Inc. | 556,455 | 440,000 | ||||
| 2025-05-15 | 13G/A | SGHT / Sight Sciences, Inc. | 2,559,003 | 3,126,508 | ||||
| 2025-05-15 | 13G/A | 0 | ||||||
| 2025-05-15 | 13G/A | HLF / Herbalife Ltd. | 5,051,000 | 4,943,000 | ||||
| 2025-05-15 | 13G/A | 380,330 | ||||||
| 2025-05-15 | 13G/A | AURA / Aura Biosciences, Inc. | 2,507,774 | 3,319,582 | ||||
| 2025-04-22 | 13G | FIP / FTAI Infrastructure Inc. | 5,701,162 | |||||
| 2025-02-11 | 13G/A | CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) | 4,487,293 | 4,617,293 | ||||
| 2025-02-11 | 13G/A | VINC / Vincerx Pharma, Inc. | 1,098,753 | 0 | ||||
| 2025-02-11 | 13G/A | CTRN / Citi Trends, Inc. | 435,673 | 556,455 | ||||
| 2025-02-11 | 13G/A | TLYS / Tilly's, Inc. | 1,831,931 | 2,181,931 | ||||
| 2025-02-11 | 13G/A | ADAPY / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) | 12,086,915 | 20,494,393 | ||||
| 2025-02-11 | 13G/A | OPRT / Oportun Financial Corporation | 1,740,777 | 1,740,777 | ||||
| 2025-02-05 | 13G | HLF / Herbalife Ltd. | 5,051,000 | |||||
| 2025-01-23 | 13G | SGHT / Sight Sciences, Inc. | 2,559,003 | |||||
| 2025-01-03 | 13G | AURA / Aura Biosciences, Inc. | 2,507,774 | |||||
| 2025-01-03 | 13G/A | AURA / Aura Biosciences, Inc. | 2,507,774 | |||||
| 2024-12-06 | 13G | AZULQ / Azul S.A. - Depositary Receipt (Common Stock) | 5,632,943 | |||||
| 2024-08-07 | 13G | CTRN / Citi Trends, Inc. | 435,673 | |||||
| 2024-04-17 | 13G | OPRT / Oportun Financial Corporation | 1,740,777 | |||||
| 2024-03-01 | 13G/A | HYZN / Hyzon Motors Inc. | 13,250,700 | 19,617,244 | ||||
| 2024-02-14 | 13G/A | TLYS / Tilly's, Inc. | 1,699,379 | 1,831,931 | ||||
| 2024-02-14 | 13G/A | VINC / Vincerx Pharma, Inc. | 1,414,951 | 1,098,753 | ||||
| 2024-02-14 | 13G/A | ONIT / Onity Group Inc. | 652,088 | 652,088 | ||||
| 2024-02-14 | 13G/A | QMCO / Quantum Corporation | 9,160,819 | |||||
| 2024-02-14 | 13G/A | CUROQ / CURO Group Holdings Corp. | 2,999,524 | 3,396,130 | ||||
| 2024-02-14 | 13G/A | HYZN / Hyzon Motors Inc. | 13,022,055 | 13,250,700 | ||||
| 2024-02-14 | 13G/A | CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) | 2,683,633 | 4,487,293 | ||||
| 2024-02-14 | 13G/A | ASPU / Aspen Group, Inc. | 2,713,592 | 2,713,592 | ||||
| 2024-02-14 | 13G/A | ADAPY / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) | 11,312,347 | 12,086,915 | ||||
| 2023-11-08 | 13G | ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) | 11,312,347 | |||||
| 2023-06-09 | 13G | CUROQ / CURO Group Holdings Corp. | 2,999,524 | |||||
| 2023-05-25 | 13G | HYZN / Hyzon Motors Inc. | 13,022,055 | |||||
| 2023-05-11 | 13G | TLYS / Tilly's, Inc. | 1,699,379 | |||||
| 2023-05-11 | 13G | QMCO / Quantum Corporation | 5,285,499 | |||||
| 2023-02-14 | 13G/A | ONIT / Onity Group Inc. | 461,666 | 652,088 | ||||
| 2023-02-14 | 13G/A | CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) | 2,542,359 | 2,683,633 | ||||
| 2023-02-14 | 13G/A | ASPU / Aspen Group, Inc. | 1,501,163 | 2,713,592 | ||||
| 2023-02-14 | 13G | VINC / Vincerx Pharma, Inc. | 1,414,951 | |||||
| 2022-05-20 | 13G | ASPU / Aspen Group, Inc. | 1,501,163 | |||||
| 2022-05-03 | 13G | CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) | 2,542,359 | |||||
| 2022-04-29 | 13G | OCN / Ocwen Financial Corporation | 461,666 | |||||
| 2019-02-13 | 13G/A | CASM / CAS Medical Systems, Inc. | 2,150,000 | 471,116 | ||||
| 2018-02-14 | 13G/A | CASM / CAS Medical Systems, Inc. | 1,940,997 | 2,150,000 | ||||
| 2017-12-01 | 13G | CASM / CAS Medical Systems, Inc. | 1,940,997 | |||||
| 2014-04-24 | 13G/A | CEI / Camber Energy, Inc. | 4,344,834 | |||||
| 2014-03-14 | 13G | CEI / Camber Energy, Inc. | 2,678,168 |
